| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,097 |
991 |
$100K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,816 |
1,692 |
$22K |
| 87631 |
|
117 |
114 |
$16K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,326 |
1,241 |
$15K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
285 |
266 |
$14K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
206 |
200 |
$9K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
895 |
814 |
$6K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
531 |
436 |
$4K |
| 87807 |
|
71 |
65 |
$837.28 |
| 85027 |
|
109 |
101 |
$573.89 |
| 81001 |
|
126 |
108 |
$447.00 |
| 80053 |
Comprehensive metabolic panel |
40 |
38 |
$394.95 |
| 90686 |
|
15 |
13 |
$124.28 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
35 |
34 |
$2.87 |